Y Intercept Hong Kong Ltd Takes Position in HCA Healthcare, Inc. $HCA

Y Intercept Hong Kong Ltd acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,682 shares of the company’s stock, valued at approximately $2,943,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of HCA. Cheviot Value Management LLC purchased a new stake in HCA Healthcare during the 1st quarter worth approximately $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare during the 1st quarter worth approximately $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare during the 1st quarter worth approximately $27,000. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $466.44 on Friday. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $478.19. The stock has a fifty day moving average of $420.00 and a two-hundred day moving average of $385.66. The firm has a market capitalization of $109.14 billion, a PE ratio of 18.03, a price-to-earnings-growth ratio of 1.38 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter in the previous year, the firm posted $4.90 EPS. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s payout ratio is currently 11.13%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. JPMorgan Chase & Co. lifted their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a research report on Wednesday, October 8th. UBS Group boosted their price objective on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research report on Monday. Raymond James Financial set a $525.00 price objective on HCA Healthcare in a research report on Monday. Finally, Robert W. Baird boosted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $473.53.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.